• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Hysteroscopy
  • Fertility
  • Hysteroscopy
  • Fertility
About Us Contact Us Login ObGFirst
Library@ObG

Test Entry – US Atlas (Library@ObG)

image_pdfFavoriteLoadingFavorite

Key Points:

General Notes

  • Exercise caution with gender discordance between NIPS and ultrasound
    • NIPS is a screening test only
    • Invasive testing (amniocentesis or CVS) is considered diagnostic
  • Gender determination should be done using both mid-sagittal and axial views

Male

  • Sagittal view
    • Penis and scrotum should be seen below the cord insertion
  • Axial view
    • Inability to differentiate penis distinctly from scrotum on axial view should raise suspicion for hypospadias or ambiguous genitalia
Figure 48 (NOTE – Top row should be labelled ‘sagittal view’ ; Lower row should be labelled ‘axial view’)

Figure 48 (NOTE – Top row should be labelled ‘sagittal view’ ; Lower row should be labelled ‘axial view’)

  1. Penis
  2. Scrotum
  3. Leg

Female

  • Sagittal view
    • In 2nd trimester, the mons pubis/female genitalia should appear flat
  • Axial view
    • Three distinct lines should be seen on axial view representing the labia
Figure 49 (NOTE – Top row should be labelled ‘sagittal view’ ; Lower row should be labelled ‘axial view’)

Figure 49 (NOTE – Top row should be labelled ‘sagittal view’ ; Lower row should be labelled ‘axial view’)

  1. Bladder
  2. Mons pubis
  3. Umbilical cord
  4. Labia
  5. Thigh

Important to Note

  • If ever in doubt as to whether findings are ‘within normal’, refer for specialized (also known as targeted or detailed) ultrasound
  • ACOG/SMFM recommends offering invasive testing using microarray for fetal structural anomalies detected on prenatal ultrasound

Learn More – Primary Sources:

Callen’s Ultrasonography in Obstetrics and Gynecology, 6th edition, ISBN 9780323328340

Locate a Maternal Fetal Medicine Specialist:

Maternal-Fetal Medicine Specialist Locator-SMFM

image_pdfFavoriteLoadingFavorite

All Library@ObG Posts

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site